Projects per year
In this paper we explore how issues of regulatory capture, the limitation of domestic 'reach' in implementing pharmaceuticals policy, and the changing global environment, play out in the case of India. What kinds of local contexts are and are not brought into play by the advisory committees constituted by the Government of India to propose changes in the regulation of pharmaceuticals since 1995? In particular, what models of Indian society and economy have underpinned these efforts, and with what kinds of effects?
|Publisher||University of Edinburgh|
|Publication status||Published - 1 Dec 2009|